Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ketone doai
Reexamination Certificate
2006-07-04
2006-07-04
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ketone doai
C514S687000, C514S559000, C514S558000, C514S616000, C514S621000, C554S063000, C424S078080, C604S266000, C623S001110, C623S011110
Reexamination Certificate
active
07071235
ABSTRACT:
A reagent and related method for use in passivating a biomaterial surface, the reagent including a latent reactive group and a bifunctional aliphatic acid (e.g., fatty acid), in combination with a spacer group linking the latent reactive group to the aliphatic acid in a manner that preserves the desired function of each group. Once bound to the surface, via the latent reactive group, the reagent presents the aliphatic acid to the physiological environment, in vivo, in a manner (e.g., concentration and orientation) sufficient to hold and orient albumin.
REFERENCES:
patent: 3992356 (1976-11-01), Jacquet et al.
patent: 4530974 (1985-07-01), Munro et al.
patent: 4722906 (1988-02-01), Guire
patent: 4973493 (1990-11-01), Guire
patent: 4979959 (1990-12-01), Guire
patent: 5002582 (1991-03-01), Guire et al.
patent: 5017670 (1991-05-01), Frautschi et al.
patent: 5073171 (1991-12-01), Eaton
patent: 5098977 (1992-03-01), Frautschi et al.
patent: 5217492 (1993-06-01), Guire et al.
patent: 5258041 (1993-11-01), Guire et al.
patent: 5263992 (1993-11-01), Guire
patent: 5512329 (1996-04-01), Guire et al.
patent: WO 88/02623 (1988-04-01), None
patent: WO 89/05616 (1989-06-01), None
patent: WO 97/34935 (1997-09-01), None
patent: WO 99/16907 (1999-04-01), None
Leonard, E.F., et al.Aron, N.Y. Acad. Sci, 516, New York, Acad. Sci., New York, 1987.
Sevastianov, V.L.,CRC Crit. Rev. Biocomp, 4:109, 1988.
“Plastics”, pp. 462-464, inConcise Encyclopedia of Polymer Science and Engineering, Kroschwitz, ed., John Wiley and Sons, 1990.
Amos Richard A.
Anderson Aron B.
Duquette Peter H.
Everson Terrence P.
Guire Patrick E.
Fredrikson & Byron , P.A.
Ghali Isis
Page Thurman K.
SurModics, Inc.
LandOfFree
Latent reactive blood compatible agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Latent reactive blood compatible agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Latent reactive blood compatible agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3537227